Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model-Reference-Cited by-同舟云学术

Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model

Published:2014-10-30 Issue:2 Volume:29 Page:464-476
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Alamo Patricia¹²,Gallardo Alberto²³,Di Nicolantonio Federica⁴⁵,Pavón Miguel Angel¹²,Casanova Isolda¹²,Trias Manuel²⁶,Mangues María Antonia⁷,Lopez‐Pousa Antonio²⁸,Villaverde Antonio²⁹,Vázquez Esther²⁹,Bardelli Alberto⁴⁵¹⁰¹¹,Céspedes María Virtudes¹²,Mangues Ramón¹²

Affiliation:

1. Oncogenesis and Antitumor Drug GroupBiomedical Research Institute Sant PauHospital de la Santa Creu i Sant PauBarcelonaSpain

2. CIBER de Bioingeniería, Biomateriales y NanomedicinaBarcelonaSpain

3. Department of PathologyClínica GironaGironaSpain

4. Department of OncologyUniversity of TorinoTorinoItaly

5. Candiolo Cancer Institute‐Fondazione del Piemonte per l'Oncologia, Istituto Di Ricovero e Cura a Carattere ScientificoTorinoItaly

6. Department of General and Digestive SurgeryHospital de la Santa Creu i Sant PauBarcelonaSpain

7. Department of PharmacyHospital de la Santa Creu i Sant PauBarcelonaSpain

8. Department of Medical OncologyHospital de la Santa Creu i Sant PauBarcelonaSpain

9. Institut de Biotecnologia i de BiomedicinaUniversitat Autònoma de BarcelonaBarcelonaSpain

10. Department de Genètica i de MicrobiologuaUniversitat Autònoma de BarcelonaBarcelonaSpain

11. FIRC Institute of Molecular OncologyMilanItaly

Funder

Instituto de Salud Carlos III

Agència de Gestió d'Ajuts Universitaris i de Recerca

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.14-262303

Reference51 articles.

1. ras GENES

2. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer;Moerkerk P.;Cancer Res.,1994

3. Kirsten ras Mutations in Patients With Colorectal Cancer: the Multicenter "RASCAL" Study

4. Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

5. A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways;Cells;2024-07-19

2. Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors;BMC Cancer;2023-07-06

3. Experimental Murine Models for Colorectal Cancer Research;Cancers;2023-04-30

4. Single-organ Pulmonary Metastasis is a favorable prognostic factor in Metastatic Colorectal Cancer Patients Treated with FOLFIRI and Vascular Endothelial Growth Factor Inhibitors;2023-01-19

5. In Silico Strategies for Designing of Peptide Inhibitors of Oncogenic K-Ras G12V Mutant: Inhibiting Cancer Growth and Proliferation;Cancers;2022-10-06